Who is sponsoring NCT02001233?

NCT02001233 is sponsored by Sinovac Biotech Co., Ltd.

What condition does NCT02001233 study?

NCT02001233 studies Hand, Foot and Mouth Disease.

What is the status of NCT02001233?

NCT02001233 is currently COMPLETED.

Last reviewed 2022-05-25 · How we verify

An Open-labelled, Multicentered, Follow-up Study for a Phase III, Efficacy Trial to Evaluate the Two-year Efficacy, Safety, and Immune Persisitence of Inactivated Enterovirus Type 71 (EV71) Vaccine

NCT02001233 COMPLETED

The purpose of this follow-up study is to evaluate the two-year efficacy, immunogenicity and safety of EV71 Vaccines in preventing Hand, Foot and Mouth disease caused by EV71 in a total 10,000 healthy infants volunteers aged from 6 to 35months old.

Details

Lead sponsor	Sinovac Biotech Co., Ltd
Status	COMPLETED
Enrolment	10077
Start date	2013-03
Completion	2014-10

Conditions

Hand, Foot and Mouth Disease

Interventions

EV71 vaccine

Primary outcomes

The incidence rate of Hand, Foot and Mouth disease caused by EV71 within the second year observation period after the second vaccination — Within the second year after the second vaccination
to evaluate the efficacy of EV71 vacccine against HFMD caused by EV71

Countries

China